Ameriprise
RPRX

Ameriprise’s Repros Therapeutics Inc. RPRX Stock Holding History

Ameriprise’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-40
Closed – – 5537
2014
Q3 		$0 Buy
40
+30
+300% +$444 ﹤0.01% 6189
2014
Q2 		$0 Hold
10
– – ﹤0.01% 5989
2014
Q1 		$0 Hold
10
– – ﹤0.01% 5659
2013
Q4 		$0 Sell
10
-41,613
-100% -$786K ﹤0.01% 5964
2013
Q3 		$1.11M Buy
41,623
+40,431
+3,392% +$866K ﹤0.01% 2648
2013
Q2 		$22K Buy
+1,192
New +$21.1K ﹤0.01% 4229

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameriprise's RPRX Position: Q4 2014 in Review

Ameriprise sold out of Repros Therapeutics Inc. (RPRX) in Q4 2014, closing a stake of 40 shares.

Ameriprise first reported a position in RPRX in Q2 2013 and held it in 6 quarters. The position peaked at $1.11M in Q3 2013. 80 funds tracked by Wall St. Rank hold RPRX as of Q4 2014.

  • Ameriprise reported no remaining Repros Therapeutics Inc. position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 40 Repros Therapeutics Inc. shares in Q4 2014.
  • Ameriprise first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 6 quarters.
  • Ameriprise's Repros Therapeutics Inc. position peaked at $1.11M in Q3 2013.
  • 80 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.